- Report
- October 2023
- 80 Pages
Brazil
From €1367EUR$1,500USD£1,168GBP
- Report
- October 2023
- 80 Pages
Argentina
From €1367EUR$1,500USD£1,168GBP
- Report
- April 2025
- 50 Pages
Global
From €2415EUR$2,650USD£2,063GBP
- Report
- March 2024
- 132 Pages
Global
From €866EUR$950USD£739GBP
Propylthiouracil (PTU) is a medication used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. It is a thioamide drug, which works by blocking the production of thyroid hormones. PTU is used to treat Graves' disease, an autoimmune disorder that causes hyperthyroidism, as well as other forms of hyperthyroidism. PTU is also used to treat thyroid storm, a rare but serious condition in which the body produces too much thyroid hormone. PTU is part of the Endocrine and Metabolic Disorders Drugs market, which includes medications used to treat a variety of endocrine and metabolic disorders. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders.
Companies in the Propylthiouracil market include Merck, Pfizer, Sanofi, and Mylan. Show Less Read more